In this issue:
BMAs are underused in patients with bone metastases from CRPC
Risk of disease recurrence after penile-sparing surgery for penile SCC
Front-line VIP chemotherapy may be a viable treatment option for germ-cell cancer
Intravesical BCG plus pembrolizumab safe for recurrent high-grade NMIBC
Adjuvant radiotherapy beneficial for pN3 SCC of the penis
RALP improves long-term survival compared to RRP
Is there still a role for cytoreductive nephrectomy for metastatic RCC?
Optimal pathological response after neoadjuvant chemotherapy for MIBC
Real-world economic burden of urothelial carcinoma after discontinuation of PD-1/L1 inhibitor therapy
Addition of abiraterone acetate plus prednisone to ADT extends PSA-free survival
Please login below to download this issue (PDF)